News | February 03, 2022
Cadila Healthcare reports Q3FY22 net profit at Rs. 500.4 Cr
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
It has a total of 50 ANDA approvals from USFDA
The need is to vaccinate people who have not contracted Covid-19
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
Subscribe To Our Newsletter & Stay Updated
